Comparison of CPAP and Gamow Bag Ventilation to Treat HAPE

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-30

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High altitude pulmonary edema (HAPE) is mostly treated with supplemental oxygen, nifedipine 30mg twice a day, rest, limiting cold exposure and descent (simulated or actual) Gamow Bag provides simulated descent and buy time for actual descent. CPAP is claimed to be effective in many case reports to treat HAPE temporarily until actual descent is taken place. This study aims to evaluate the role of CPAP in treating HAPE at those high altitude stations where Gamow bag is not available and immediate descent is not possible.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP)

NCT04014088

Acute Cardiogenic Pulmonary Edema

COMPLETED NA

Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema

NCT00390442

Cardiogenic Pulmonary Edema

COMPLETED PHASE3

Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema

NCT00912158

Acute Cardiogenic Pulmonary Edema

COMPLETED PHASE4

Continuous Positive Airway Pressure for Acute Pulmonary Edema

NCT00554580

Pulmonary Edema Dyspnea Paroxysmal +1 more

COMPLETED PHASE3

OUT-OF-HOSPITAL CPAP STUDY

NCT00439075

Acute Cardiogenic Pulmonary Edema

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Swenson described HAPE in 2002, as a form of hydrostatic acute pulmonary edema with an alteration of alveolar-capillary permeability. Overall prevalence of AMS is 10-20% while incidence of HAPE, HACE or mixed incidence is 2-3%. Highest reported incidence of HAPE among Indian soldiers climbing to Siachen glacier is 15.5%. At 1500-2400m, A series of 52 patients admitted for HAPE over a period of 9 years was reported in literature..

Scientific rationale:

Positive pressure has been used to increase altitude tolerance since the 1940s under simulated altitudes. PEEP applied via face mask increased SpO2 and decreased AMS symptoms. CPAP was used after ascent to 3205 m on Mount Cook in New Zealand where it improved SpO2 and reduced symptoms of HAPE. A CPAP helmet providing 15 cmH20 CPAP improved SpO2 in a single HAPE patient (at 5300 m) from 56% to 74%.-1st case report. A study at Thorang La pass (5416 m) in October 2010 in the Nepal Himalaya found that nasal continuous positive airway pressure (CPAP) is useful as an additional modality to treat presumed high altitude pulmonary edema (HAPE)- 2nd case report.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

High Altitude Pulmonary Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Study Design: Randomised control trial Settings: Posts more than 8000 feet (2400m) where Medical officer is available Study Duration: 01 year after the study is approved Sampling Technique: Non probability consecutive sampling Distribution of patients in to two groups (Gp A and Gp B) by consecutive sampling Group "A" will be given CPAP in addition to standard of care and Group B will be offered Gamow bag in addition to standard of care

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CPAP arm

In addition to standard of care, CPAP will be provided at high altitude posts where Gamow bag is not available and all patients of HAPE will be given CPAP when evacuation/descent is either not possible or delayed due to weather conditions.

Group Type EXPERIMENTAL

Continuous positive airway pressure machine

Intervention Type DEVICE

CPAP device set at 6-8cmH2O for several hours

Gamow bag arm/hyperbaric chamber

Posts where Gamow bag would be available, the patients of HAPE will be given standard of care and will be asked to lie inside Gamow bag inflated at 2 Psi for several hours to simulate a descent of 1500 meters when evacuation/descent is either not possible or delayed due to weather conditions.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous positive airway pressure machine

CPAP device set at 6-8cmH2O for several hours

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CPAP-REMstar pro (system one 60 series)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male gender
* Age 18-45 years
* Previously fit and no comorbids
* Suspected HAPE

--arrived in the past 01 week on the post
* Expected evacuation from post more than 8 hours

Exclusion Criteria

* Symptoms suggest acute infective etiology.
* Symptoms after one week of stay at HA
* Altered mental status.
* Disturbed balance
* Visual impairment
* Severe headache
* A speedy evacuation to a lower height is available

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes